5-Hydroxytryptophan (5-HTP) Market Report

5-Hydroxytryptophan (5-HTP) Market Analysis, Market Size, Application Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2014 To 2020

Format: PDF  |  Report ID: GVR1184

Global 5-Hydroxytryptophan (5-HTP) market is expected to grow owing to increasing stress levels in individuals on account of hormonal changes and improper diet resulting in decrease of serotonin level over the forecast period. Increasing anti-depressants demand due to growing prevalence of anxiety, induced loss of appetite and pain sensation is anticipated to propel 5-HTP market demand over the next six years. Irregular supply and fluctuating raw material prices are expected to act as a restraint for the market growth. In addition, stringent government regulations and lack of awareness among end users is anticipated to pose a challenge for 5-HTP market participants. Furthermore, existing side effects of 5-HTP including stomach pain, heartburn, nausea, diarrhea, vomiting, muscle problems and drowsiness is estimated to hinder market growth. Increasing use of eco-friendly 5-HTP as a substitute for chemically synthesized tryptophan is expected to fuel market growth over the forecast period. In addition, R&D in genetic components is expected to cater to market growth opportunities.

North America was the largest consumer for 5-HTP over the past five years followed by Europe and Asia Pacific. Asia Pacific is expected to witness high growth in terms of consumption and production of 5-HTP owing to emergence of numerous small and medium sized manufacturers over the forecast period. Furthermore, changing lifestyle has led to huge capacity expansions in Asia Pacific. Technological advancements in emerging economies such as India and China have potential growth opportunities; although unfavorable drug regulations and lack of awareness could pose challenges to the market demand. Increasing applications in pharmaceuticals, food & beverage and dietary supplements are estimated to augment market growth over the next six years. Dietary supplements are expected to witness swift growth owing to increasing demand for artificial body nutrients. Increasing consumption of 5-HTP for treatment of insomnia, anxiety, depression, fibromyalgia, migraine, binge eating associated with obesity, attention deficit-hyperactivity disorder (ADHD), premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), Parkinson's disease and seizure disorder is anticipated to have positive impact on the market share.

Key players in 5-HTP market include Flynn Pharma Ltd., Fidia Farmeceutici Spa, Linnea SA, Aspen Pharma, Chemill Inc, Takeda Pharmaceuticals International GmbH, Cactus Botanics, SanHerb Biotech Co. Ltd. and Jiaherb Inc. 

Key questions answered by the report
Request for Customization

Choose License Type:

Single User - $4,950
Multi User - $7,950
Enterprise User - $9,950

Special Pricing & Discounts

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA